HAE
Haemonetics Corporation
NYSE · Healthcare · Medical - Instruments & Supplies · US
$102.92
+0.07%Forward multiples
Based on analyst estimates
- P/E forward
- 18.80x
- P/E 2026E
- 19.42x
- P/E 2027E
- 17.93x
- P/E 2028E
- 16.17x
- P/S forward
- 3.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- 49.96x
- PEG TTM
- 0.30x
- Price / book
- 5.59x
- Price / sales
- 3.46x
- Price / cash flow
- 14.27x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 4.17x
- EV / EBITDA
- 21.57x
- EV / EBIT
- 22.92x
- Market cap
- $4.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026